ACKNOWLEDGEMENT
This activity is supported by educational grants from Merck and Lilly USA, LLC

TUITION
Free

ACCREDITATION STATEMENT 
Joslin Diabetes Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENTS 
Joslin Diabetes Center designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 


DATE OF RELEASE/EXPIRATION
The enduring material will be available from December 18, 2020 – December 18, 2021

LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:

  • Demonstrate the ability to identify common glycemic control problems and treatment barriers, and then recommend individualized therapeutic approaches that also address patient self-care issues and comorbidities as needed.
  • Identify key recommendations from national diabetes treatment guidelines that can drive individualized therapeutic decisions for glycemic control in people with diabetes.
  • Recognize medical and self-care characteristics for each patient and utilize the identification of those characteristics to individualize therapeutic recommendations for patients with Type 1 Diabetes and Hypoglycemia,
     

INTENDED AUDIENCE
Physicians, caregivers of people with diabetes in the hospital setting.
 

METHOD OF PARTICIPATION.
To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the posttest and activity evaluation. It is estimated that this module will take approximately 2 hours to complete.
 

HARDWARE/SOFTWARE REQUIREMENTS
Participants will need a computer, tablet, or smartphone, as well as an internet connection sufficient for streaming media. 

T2DM Subopt Met Next Rx.

Presented by Joslin Diabetes Center

ACKNOWLEDGEMENT
This activity is supported by educational grants from Merck and Lilly USA, LLC

TUITION
Free

ACCREDITATION STATEMENT 
Joslin Diabetes Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENTS 
Joslin Diabetes Center designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 


DATE OF RELEASE/EXPIRATION
The enduring material will be available from January 7, 2021 – January 7, 2022

LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:

  • Demonstrate the ability to identify common glycemic control problems and treatment barriers, and then recommend individualized therapeutic approaches which also address patient self-care issues and comorbidities as needed.
  • Identify key recommendations from national diabetes treatment guidelines that can drive individualized therapeutic decisions for glycemic control in people with diabetes.
  • Recognize medical and self-care characteristics for each patient and utilize the identification of those characteristics to individualize therapeutic recommendations for patients with Type 1 Diabetes and Hypoglycemia,

INTENDED AUDIENCE

Physicians, caregivers of people with diabetes in the hospital setting.

METHOD OF PARTICIPATION.

To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the posttest and activity evaluation. It is estimated that this module will take approximately 2 hours to complete.

 

HARDWARE/SOFTWARE REQUIREMENTS
Participants will need a computer, tablet, or smartphone, as well as an internet connection sufficient for streaming media. 

FACULTY DISCLOSURES 
As part of its accreditation with the Accreditation Council for Continuing Medical Education, Joslin Diabetes Center must disclose to the audience of a Joslin continuing medical education activity the existence of any relevant financial relationships between Joslin and/or its planning and/or CME advisory committee members, speakers, and their spouses/partners and commercial entities. Joslin and its planning and CME advisory committee members and speakers must disclose any relationships they and their spouses/partners have or have had in the prior 12 months with proprietary entities producing healthcare goods or services, with the exception of nonprofit or government organizations and non-healthcare-related companies, which are exempt.

Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fees, honoraria, ownership interests (e.g., stocks, stock options, or other ownership interest, excluding diversified mutual funds), or other financial benefit in any amount. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected.

If a faculty or planning committee member has no information to disclose, this information will also be provided. If a faculty or planning committee member refuses to disclose, he/she will not be able to participate in the planning, management, presentation, or evaluation of any Joslin Diabetes Center CME activity. In addition, faculty have been asked to disclose when a product or device is not labeled for the use under discussion. The opinions and comments expressed in this program are those of the speakers and should not be considered the opinions or comments of Joslin Diabetes Center.

The planners and faculty have reported the following financial relationships with commercial interests. Via Joslin internal review, any relationship deemed relevant to the content of this activity has been identified and resolved through Joslin’s internal processes.

The faculty and planning committee members for this program have disclosed the following:

Faculty

  • Richard S. Beaser, Senior Staff Physician and Medical Director of CME, Joslin Diabetes Center, has no relevant financial relationships to disclose.
  • Samar Hafida, MD, Staff Physician and Assistant Medical Director, Global Education and Care Weight Management and Clinical Nutrition Specialist, Joslin Diabetes Center, has no relevant financial relationships to disclose.

Joslin CME Advisory Committee

  • Jerry Cavallerano, OD, Optometrist, Beetham Eye Institute, Joslin Diabetes Center, has no relevant financial relationships.
  • Nuha El Sayed, MD, Staff Physician and Medical Director, Professional Education, Joslin Diabetes Center, has no relevant financial relationships.
  • Erin Kelly, M.Ed., RN, BSN, CDE, Adult Diabetes Educator, Joslin Diabetes Center, holds stock in Tandem Diabetes Care.
  • Lyle Mitzner, MD, Staff Physician, Joslin Diabetes Center, is a shareholder with Conversa Health.
  • Alissa Segal, Pharm D, CDE, CDTC, FCCP, Clinical Pharmacist, Joslin Diabetes Center, has no relevant financial relationships with regard to this activity.
  • Robert C. Stanton, MD, Chief of Nephrology, Joslin Diabetes Center, has no relevant financial relationships
  • Elena Toschi, MD, Staff Physician, Joslin Diabetes Center, has no relevant financial relationships.

CONTACT INFORMATION
Please send content inquiries, technical problems or issues with your CME certificate to: cme [at] joslin.harvard.edu

DISCLAIMERS (if applicable):

The material is prepared based on a review of multiple sources of information but is not exhaustive of the subject matter. Therefore, health care professionals and other individuals should review and consider other publications and materials about the subject matter other than relying solely on the information contained in this material.

 

Presented by Joslin Diabetes Center

ACKNOWLEDGEMENT
This activity is supported by educational grants from Merck and Lilly USA, LLC.

TUITION
Free

ACCREDITATION STATEMENT 
Joslin Diabetes Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENTS 
Joslin Diabetes Center designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 


DATE OF RELEASE/EXPIRATION
The enduring material will be available from March 11, 2021 – March 11, 2022

LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:

  • Identify key recommendations from national diabetes treatment guidelines that can drive individualized therapeutic decisions for glycemic control in people with diabetes.
  • Demonstrate the ability to identify common glycemic control problems and treatment barriers, and then recommend individualized therapeutic approaches which also address patient self-care issues and comorbidities as needed.
  • Recognize medical and self-care characteristics for each patient and utilize the identification of those characteristics to individualize therapeutic goals and recommendations for older people with type 2 diabetes.

INTENDED AUDIENCE

Physicians, caregivers of people with diabetes in the hospital setting.

METHOD OF PARTICIPATION.

To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the posttest and activity evaluation. It is estimated that this module will take approximately 2 hours to complete.

 

HARDWARE/SOFTWARE REQUIREMENTS
Participants will need a computer, tablet, or smartphone, as well as an internet connection sufficient for streaming media. 

FACULTY DISCLOSURES 
As part of its accreditation with the Accreditation Council for Continuing Medical Education, Joslin Diabetes Center must disclose to the audience of a Joslin continuing medical education activity the existence of any relevant financial relationships between Joslin and/or its planning and/or CME advisory committee members, speakers, and their spouses/partners and commercial entities. Joslin and its planning and CME advisory committee members and speakers must disclose any relationships they and their spouses/partners have or have had in the prior 12 months with proprietary entities producing healthcare goods or services, with the exception of nonprofit or government organizations and non-healthcare-related companies, which are exempt.

Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fees, honoraria, ownership interests (e.g., stocks, stock options, or other ownership interest, excluding diversified mutual funds), or other financial benefit in any amount. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected.

If a faculty or planning committee member has no information to disclose, this information will also be provided. If a faculty or planning committee member refuses to disclose, he/she will not be able to participate in the planning, management, presentation, or evaluation of any Joslin Diabetes Center CME activity. In addition, faculty have been asked to disclose when a product or device is not labeled for the use under discussion. The opinions and comments expressed in this program are those of the speakers and should not be considered the opinions or comments of Joslin Diabetes Center.

The planners and faculty have reported the following financial relationships with commercial interests. Via Joslin internal review, any relationship deemed relevant to the content of this activity has been identified and resolved through Joslin’s internal processes.

The faculty and planning committee members for this program have disclosed the following:

Faculty

  • Richard S. Beaser, MD, Senior Staff Physician and Medical Director of CME, Joslin Diabetes Center, has no relevant financial relationships to disclose.
  • Medha Munshi, MD, Director, Geriatric Diabetes Program, Joslin Diabetes Center and Associate Professor of Medicine, Harvard Medical School has no relevant financial relationships to disclose.

Joslin CME Advisory Committee

  • Jerry Cavallerano, OD, Optometrist, Beetham Eye Institute, Joslin Diabetes Center, has no relevant financial relationships to disclose.
  • Nuha El Sayed, MD, Staff Physician and Medical Director, Professional Education, Joslin Diabetes Center, has no relevant financial relationships to disclose.
  • Erin Kelly, M.Ed., RN, BSN, CDE, Adult Diabetes Educator, Joslin Diabetes Center, holds stock in Tandem Diabetes Care.
  • Lyle Mitzner, MD, Staff Physician, Joslin Diabetes Center, has no relevant financial relationships to disclose.
  • Alissa Segal, Pharm D, CDE, CDTC, FCCP, Clinical Pharmacist, Joslin Diabetes Center, has no relevant financial relationships to disclose.
  • Robert C. Stanton, MD, Chief of Nephrology, Joslin Diabetes Center, has no relevant financial relationships to disclose.
  • Elena Toschi, MD, Staff Physician, Joslin Diabetes Center, has no relevant financial relationships to disclose.

CONTACT INFORMATION
Please send content inquiries, technical problems or issues with your CME certificate to: cme [at] joslin.harvard.edu

DISCLAIMERS (if applicable):

The material is prepared based on a review of multiple sources of information but is not exhaustive of the subject matter. Therefore, health care professionals and other individuals should review and consider other publications and materials about the subject matter other than relying solely on the information contained in this material.

Joslin CME Advisory Committee

Richard Beaser
Richard Beaser, MD
Senior Staff Physician
Clinical Investigator
Medical Director, Continuing Medical Education
Associate Clinical Professor of Medicine, Harvard Medical School
Jerry Cavallerano
Jerry Cavallerano, OD, PhD
Optometrist
Assistant Director, Beetham Eye Institute
Clinical Investigator
Associate Professor of Ophthalmology, Harvard Medical School
Nuha Ali El Sayed
Nuha Ali El Sayed, MD, MMSc
Staff Physician
Medical Director, Professional Education
Medical Director, Training Programs and Visitor Program
Instructor in Medicine, Harvard Medical School
Erin Kelly
Erin Kelly, MEd, BSN, RN, CDE
Clinical Manager, Educational Services
Nurse Educator
Lyle Mitzner
Lyle Mitzner, MD
Staff Physician
Assistant Professor of Medicine, Harvard Medical School
Robert Stanton
Robert Stanton, MD
Staff Physician
Chief, Kidney & Hypertension Section
Investigator
Associate Professor of Medicine, Harvard Medical School
Elena Toschi
Elena Toschi, MD
Staff Physician
Director, Young Adult Clinic
Research Associate
Assistant Professor of Medicine, Harvard Medical School

As part of its accreditation with the Accreditation Council for Continuing Medical Education, Joslin Diabetes Center must disclose to the audience of a Joslin continuing medical education activity the existence of any relevant financial relationships between Joslin and/or its planning and/or CME advisory committee members, speakers, and their spouses/partners and commercial entities. Joslin and its planning and CME advisory committee members and speakers must disclose any relationships they and their spouses/partners have or have had in the prior 12 months with proprietary entities producing healthcare goods or services, with the exception of nonprofit or government organizations and non-healthcare-related companies, which are exempt.

Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fees, honoraria, ownership interests (e.g., stocks, stock options, or other ownership interest, excluding diversified mutual funds), or other financial benefits in any amount. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected.

If a faculty or planning committee member has no information to disclose, this information will also be provided. If a faculty or planning committee member refuses to disclose, he/she will not be able to participate in the planning, management, presentation, or evaluation of any Joslin Diabetes Center CME activity. In addition, faculty have been asked to disclose when a product or device is not labeled for the use under discussion. The opinions and comments expressed in this program are those of the speakers and should not be considered the opinions or comments of Joslin Diabetes Center.

The planners and faculty have reported the following financial relationships with commercial interests. Via Joslin internal review, any relationship deemed relevant to the content of this activity has been identified and resolved through Joslin’s internal processes.

Faculty

  • Dr. Richard S. Beaser, Senior Staff Physician and Medical Director of CME, Joslin Diabetes Center, has no relevant financial relationships to disclose.
  • Alissa Segal, Pharm D, CDE, CDTC, FCCP, Clinical Pharmacist, Joslin Diabetes Center, has no relevant financial relationships with regard to this activity.

 

Joslin CME Advisory Committee

  • Jerry Cavallerano, OD, Optometrist, Beetham Eye Institute, Joslin Diabetes Center, has no relevant financial relationships.
  • Nuha El Sayed, MD, Staff Physician and Medical Director, Professional Education, Joslin Diabetes Center, has no relevant financial relationships.
  • Erin Kelly, M.Ed., RN, BSN, CDE, Adult Diabetes Educator, Joslin Diabetes Center, holds stock in Tandem Diabetes Care.
  • Lyle Mitzner, MD, Staff Physician, Joslin Diabetes Center, is a shareholder with Conversa Health.
  • Alissa Segal, Pharm D, CDE, CDTC, FCCP, Clinical Pharmacist, Joslin Diabetes Center, has no relevant financial relationships with regard to this activity.
  • Robert C. Stanton, MD, Chief of Nephrology, Joslin Diabetes Center, has no relevant financial relationships
  • Elena Toschi, MD, Staff Physician, Joslin Diabetes Center, has no relevant financial relationships.

The material is prepared based on a review of multiple sources of information but is not exhaustive of the subject matter. Therefore, health care professionals and other individuals should review and consider other publications and materials about the subject matter other than relying solely on the information contained in this material.

Please send content inquiries, technical problems or issues with your CME certificate to cme [at] joslin.harvard.edu